Verge Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.3/10
Best for: price-transparent compounded GLP-1 with a no-subscription one-time order option
Price is where Verge scores best in our breakdown.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Verge (Verge Health Group LLC) is a WooCommerce-based telehealth storefront selling compounded semaglutide and tirzepatide, with care delivered by TelegraMD's provider network. It charges one price at every dose and offers one-time 1- and 3-month orders or auto-renewing subscriptions. Compounded semaglutide works out to about $148 a month on the 3-month subscription ($390 every 80 days) and tirzepatide to about $240 a month on a one-time 3-month order ($720).
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Verge
MEDVi
Best for: switching between compounded and brand-name GLP-1 through one provider
Editorial score · methodology
DudeMeds
Best for: men seeking no-fee compounded or brand-name GLP-1 injections
Editorial score · methodology
Oak
Best for: compounded semaglutide and tirzepatide at a low starting price, with a full price list before you sign up
Editorial score · methodology
Verge at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $148/mo
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored Verge
Each dimension is scored algorithmically from Verge’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
8.2/10At $148/mo, Verge runs about 17% below the $179 median for GLP-1 providers. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
7.8/10Verge offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.1/10Online intake and platform experience — consult included in the price; 7 platform features disclosed.
Trust & Safety15%
7.0/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
5.8/10Verge's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
5.6/10Verge provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Verge review
Last checked October 2026- Confirmed current pricing across 8 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $148–$329/mo across 8 dose/plan tiers — checked October 2026
- State pharmacy licensing & LegitScript status
- LegitScript Verified
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Verge
We walked Verge’s public signup flow in October 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Pick a program on the weight-loss page: compounded semaglutide or compounded tirzepatide
- 2Get Started opens a plan picker: 1-month or 3-month supply, then subscribe-and-save or one-time purchase
- 3Add to cart; the cart shows the charge due today and, for subscriptions, the recurring amount and first renewal date
- 4Checkout asks for billing and shipping address and card details before the health intake
- 5Per the FAQ, a licensed provider then reviews your intake, usually within one business day; the card charge only goes through if you're approved
- 6If approved, the pharmacy prepares and ships the order; the FAQ asks you to allow 7 to 10 business days
- Walked the public funnel only: added plans to the cart and opened checkout, but created no account, entered no personal or health data and paid nothing
- The cart states the real cadence: '$390.00 every 80 days' for the 3-month semaglutide subscription and '$170.00 every 25 days' for the 1-month one
- The advertised $130/mo and $170/mo figures understate the cost; at those cadences they work out to about $148 and $207 a month
- The one-time orders ($175 or $450 for semaglutide, $275 or $720 for tirzepatide) don't renew, and the 3-month one-time semaglutide order costs about the same per month as the subscription
- You pay at checkout before any clinical review. The FAQ says this is a pending charge that falls off if you're not approved
- The product disclaimer says the product 'does not contain subscriptions or auto-renewals', which contradicts the subscription plans sold beside it
- The tirzepatide 3-month subscription's product text says it renews every 11 weeks, but the cart says every 80 days
Verge customer support
GLP-1 medications Verge offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Peptides Verge offers
Beyond GLP-1s, Verge also offers these peptides — tap any for our evidence-based guide.
Pricing
Prices re-verified
$390 charged every 80 days, about $148 a month. The site advertises this plan as $130/mo, which divides $390 by three months even though it renews every 80 days.
$450 paid upfront for a 3-month supply, about $150 a month. No subscription.
$175 for a 1-month supply. No subscription.
$170 charged every 25 days, about $207 a month. The site advertises this plan as $170/mo.
$720 paid upfront for a 3-month supply, about $240 a month. No subscription.
$705 charged every 80 days, about $268 a month. The site advertises this plan as $235/mo.
$275 for a 1-month supply. No subscription.
$270 charged every 25 days, about $329 a month. The site advertises this plan as $270/mo.
Ready to get started?
Plans and promotions change often — check Verge's current pricing and active discounts before you decide.
What we like
- Every plan price is listed on the weight-loss page before you start, and it is the same at every dose
- One-time 1- and 3-month orders are offered alongside subscriptions, so you don't have to auto-renew
- Shipping is free, and the FAQ says there are no membership fees
- If you aren't approved, the FAQ says the pending charge on your card drops off and you aren't billed
- Footer carries LegitScript's issued seal for startverge.com
- Names its clinical partner: care is delivered through TelegraMD's licensed provider network
Watch-outs
- Subscriptions renew every 25 or 80 days, so the advertised $170/mo plan really costs about $207 a month
- The $130/mo headline is $390 divided by three, but that plan recharges every 80 days (about $148 a month)
- Product disclaimers say there are no subscriptions or auto-renewals, while the same page sells subscriptions
- Compounding pharmacies are not named, only an FDA-registered or partner pharmacy
- Advertises all 50 states, but its terms say service is available only in certain states, with no list
- All sales are final once you are approved, and consult fees are not refundable
- No support phone line; help is by email, chat and the patient portal
- Only 17 Trustpilot reviews (3.7 out of 5), and the terms still contain an unfilled [ENTITY NAME] placeholder
Is Verge worth it?
Verge's whole pitch comes down to this: price-transparent compounded GLP-1 with a no-subscription one-time order option. It runs $148/month at every dose — toward the affordable end of the category, so cost isn't the reason to look elsewhere. Its flat, all-dose pricing is a genuine plus for anyone worried about cost climbing as they titrate up.
Verge is LegitScript-certified. It also charges the same price at every dose and charges no membership fee.
How much Verge actually costs
Compounded semaglutide runs $148–$207/month depending on plan and compounded tirzepatide runs $240–$329/month depending on plan.
That puts Verge below the roughly $179 median ongoing price across the GLP-1 providers we track — a real cost advantage.
Gala (about $149/month) is one of the closest alternatives to weigh Verge against.
Medications: what Verge prescribes
Verge prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two most-studied weight-loss molecules on the market today. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products — the standard trade-off across the compounded-GLP-1 market.
Who Verge is best for — and who should skip it
A good fit if you…
- are focused on the lowest ongoing monthly cost — $148/month is below the roughly $179 median we track across the category.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation — that's not what this provider fills.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
We found no FDA warning letter on file for it, though a clean record isn't the same as an endorsement — read the rest of this review for the full picture. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Verge earns its place on the shortlist mainly on price: at $148/month it's one of the more affordable ways to stay on a GLP-1, without obvious corners cut on access or oversight.
The Bottom Line
Price is where Verge scores best in our breakdown.
Ready to start with Verge?
Starting at $148/month. See current pricing and start your free consultation.
Verge might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider altRX.
- If the lowest possible monthly price is your top priority, consider Collective (from $59/mo).
- If you want built-in coaching and behavior-change support, consider MEDVi.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Verge review:
Sources & methodology — as of October 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Verge's current pricing
Plans start at $148/month. Start your free consultation to check eligibility and today's price.